DrugId:  1
1. Name:  R667
2. Groups:  Investigational
3. Description:  R667 is an orally active, gamma selective retinoid agonist that shows promise as a treatment for emhysema, as it has, in animal models, promoted structural lung repair and functional improvement with fewer side effects. It is currently in Phase II Trials for emphysema secondary to alpha-1 antitrypsindeficiency.
4. Indication:  Investigated for use/treatment in emphysema.
DrugId:  2
1. Name:  Terbutaline
2. Groups:  Approved
3. Description:  A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic. [PubChem]
4. Indication:  For the prevention and reversal of bronchospasm in patients 12 years of age and older with reversible, obstructive airway disease, as well as symptomatic management of reversible bronchospasm associated with bronchitis and emphysema. Also used acute IV and sub-Q therapy in selected women to inhibit uterine contractions in preterm labor (tocolysis) and prolong gestation when beneficial.
DrugId:  3
1. Name:  Alpha-1-proteinase inhibitor
2. Groups:  Approved
3. Description:  Human alpha-1 proteinase inhibitor or alpha-1-antitrypsin, prepared from human plasma via Cohn alcohol fractionation followed by PEG and zinc chloride fractionation.
4. Indication:  For chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor (A1-PI) deficiency and clinical evidence of emphysema.
DrugId:  4
1. Name:  Streptococcus pneumoniae type 12f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 12f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 12f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  5
1. Name:  Streptococcus pneumoniae type 19f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 19f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 19f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  6
1. Name:  Streptococcus pneumoniae type 23f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 23f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 23f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  7
1. Name:  Dyphylline
2. Groups:  Approved
3. Description:  A theophylline derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis. [PubChem]
4. Indication:  For relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema.
DrugId:  8
1. Name:  Streptococcus pneumoniae type 6b capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 6b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 6b of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  9
1. Name:  Streptococcus pneumoniae type 7f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 7f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 7f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  10
1. Name:  Streptococcus pneumoniae type 8 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 8 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 8 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  11
1. Name:  Streptococcus pneumoniae type 11a capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 11a capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 11a of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  12
1. Name:  Streptococcus pneumoniae type 17f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 17f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 17f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  13
1. Name:  Streptococcus pneumoniae type 18c capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 18c capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 18c of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  14
1. Name:  Streptococcus pneumoniae type 20 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 20 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 20 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  15
1. Name:  Talimogene laherparepvec
2. Groups:  Approved, Experimental, Investigational
3. Description:  Talimogene laherparepvec is an oncolytic treatment used in local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in patients with recurrent melanoma. It is a genetically administered herpes simplex virus 1 (HSV-1) that expresses human cytokine granulocyte-macrophage colony stimulating factor (GM-CSF) with antitumor and immune-stimulating activities. It specifically replicates within tumor cells and causes lysis. It was approved by the FDA in 2015 under the market name Imlygic.
4. Indication:  Not Available
DrugId:  16
1. Name:  Streptococcus pneumoniae type 2 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 2 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 2 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  17
1. Name:  Streptococcus pneumoniae type 3 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 3 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 3 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  18
1. Name:  Streptococcus pneumoniae type 15b capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 15b capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 15b of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  19
1. Name:  Streptococcus pneumoniae type 22f capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 22f capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 22f of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  20
1. Name:  Streptococcus pneumoniae type 4 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 4 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 4 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  21
1. Name:  Isoetarine
2. Groups:  Approved
3. Description:  Isoetarine is a selective adrenergic beta-2 agonist used as fast acting bronchodilator for emphysema, bronchitis and asthma. [PubChem]
4. Indication:  For the treatment of asthma, wheezing, and chronic asthmatic bronchitis.
DrugId:  22
1. Name:  Bambuterol
2. Groups:  Approved, Investigational
3. Description:  Bambuterol is a long acting beta-adrenoceptor agonist used in the treatment of asthma. It is a prodrug of terbutaline.
4. Indication:  For the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.
DrugId:  23
1. Name:  Adomiparin
2. Groups:  Investigational
3. Description:  Not Available
4. Indication:  Investigated for use/treatment in cardiovascular disorders and coronary artery disease.
DrugId:  24
1. Name:  Streptococcus pneumoniae type 1 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 1 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 1 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
DrugId:  25
1. Name:  Streptococcus pneumoniae type 5 capsular polysaccharide antigen
2. Groups:  Approved
3. Description:  Streptococcus pneumoniae type 5 capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 5 of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
4. Indication:  Not Available
